Ended: 17-Jul-18 18:31:55
5d 16h 7m left
1h 44m left
A new fetal electrocardiogram (ECG) technology designed to be used along with conventional fetal heart rate monitoring contributes little benefit in reducing complications during childbirth, according to a study by the National Institutes of Health. The new technology, which tracks the electrical activity of the fetal heart, neither reduced the risk for a number of outcomes that included fetal and neonatal deaths nor did it have any significant effect on the rates of cesarean or operative... The findings have been published in The New England Journal of Medicine. Researchers divided more than 11,000 pregnant women into two groups when they went into labor after the 36th week of pregnancy. The first group received readings from both the ECG ST monitors and fetal heart rate monitors, while the second group were hooked up to only the fetal heart rate monitor. "The study authors compared a number of outcomes … and found no significant differences," Dr. Uma Reddy, medical officer at NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development, said in a statement. "Our study didn't find any benefit for ECG ST monitoring in term births. The technology is referred to as fetal ST segment analysis and derives its name from the ST interval, which is the brief space of time after a heartbeat when the heart cannot contract again until heart cells recover from the electrical impulse... ECGs are commonly used to detect abnormal heart rates, heart attacks and other heart problems, but are rarely used in the U. S. to monitor fetal heart rates. Typically, physicians have monitored only the fetal heart rate during labor. Unrelated to the study, Israeli startup Nuvo Group is developing a mobile fetal monitor that helps physicians screen for symptoms that may lead to complications during pregnancy. The device sends the information to a smartphone and stores it to a cloud-based database, providing data on heart rate, movement and fetal position. Earlier this year, Philips ( $PHG ) got FDA clearance for a cableless fetal monitor that will allow women more freedom of movement during labor. - see the NIH release. - check out the abstract in The New England Journal of Medicine. Related Articles:. Israeli startup unveils cloud-based mobile fetal monitor. Philips receives FDA clearance for. Source: www.fiercemedicaldevices.com
A new technology that tracks the electrical activity of the fetal heart offers no advantages over conventional technology in preventing birth complications, according to a new study by the National Institutes of Health. The technology provides electrocardiogram (ECG) readings of a fetus’s heart during the birth process. An ECG records the heart’s electrical activity — the signal that spreads from the top of the heart to the bottom, causing the heart to contract and pump blood. ECGs are typically used to detect abnormal heart rates, heart attacks, and other heart problems, but they are not commonly used to monitor fetuses in the United States. Traditionally, physicians have monitored only the fetal heart rate, the pace at which the heart is beating, during labor. The findings appear in the New England Journal of Medicine. The study’s principal investigators are Michael A. Belfort, M. D. , Ph. D, of the University of Utah Health Sciences Center in Salt Lake City when the study began, and now at Baylor College of Medicine, Houston, and George Saade, M. D. , of the... The new technology is referred to as fetal ST segment analysis, named for the ST interval — the time after a heartbeat, when the heart cannot contract again until the heart cells recover from the electrical impulse that triggered the beat. The idea behind fetal ECG ST monitoring was that additional information about the heart would alert delivery room staff earlier than would heart rate monitoring alone, allowing them to intervene earlier to prevent potential complications. “The study authors compared a number of outcomes — fetal and newborn death, seizures, and cesarean delivery — and found no significant differences,” said Uma Reddy, M. D. , medical officer at NIH’s Eunice Kennedy Shriver National Institute of... Reddy added that the investigators saw no difference between the groups, whether they considered potential outcomes individually or all together in a primary (combined) outcome. The study was conducted by researchers in the NICHD Maternal-Fetal Medicine Units Network , which conducts studies on birth, delivery, and newborn medicine. For the study, more than 11,000 pregnant women were assigned to one of two groups when they went into labor after the 36th week of pregnancy. Physicians. Source: www.nih.gov
District Court of Appeals has encouraged the Supreme Court to redefine the standard by which states have the authority to limit abortion. Now that authority is defined by whether or not a baby can live outside a mother’s womb. The Eighth Circuit suggests that in light of modern science, the high court should limit abortions where the unborn child possesses a heartbeat. The Eighth Circuit wrote that state legislatures, not judicial bodies, should determine medical science as it relates to when an abortion is allowed and questioned using a “fetal viability analysis” because of modern medical advances. Supreme Court has ruled that a child cannot live outside of the womb before 24 weeks. The photo above shows an ultrasound and fetal heartbeat monitor of a six-week, six-day-old, unborn child. Located in American’s heartland in St. Louis, Missouri, the panel of judges wrote that the issue before it was “whether, given the current state of medical science, a state generally may prohibit physicians from aborting unborn children who... The North Dakota statute at issue in the case reads as one of the most protective of fetal life in the country. In 2013, the legislature in North Dakota passed House Bill 1456 which extended the general prohibition on abortion (prior to “viability”) to the point where the unborn child has a detectable heartbeat. The statute contains exceptions for the life or health of the pregnant woman and for the life of another unborn child. A physician who violates this statute commits a felony. The sole abortion provider in N. Dakota filed suit, and the attorney general represented the state in defending the constitutionality of the statute. The plaintiff abortion providers submitted evidence that a fetal heart beat can be detected at about 6 weeks but a fetus is not viable until about 24 weeks. The state submitted evidence that a child’s heartbeat is detectable by about 6 to 8 weeks. Further, an unborn child is viable from conception because in vitro fertilization allows an embryonic unborn child to live outside the womb for two to six days after conception. This has been commonly referred to as “test tube babies. The Eighth Circuit reluctantly held, “Because United States Supreme Court precedent does not permit us to reach a contrary result,” we affirm the decision of the lower court. Source: www.breitbart.com
On the other hand, HRV detected with an external monitor could be a more ... “Future pregnancy management should be noninvasive, reliable and accessible for everyone.” The study, “Fetal heart rate and fetal heart rate variability in Lipizzaner ...